KATELYNN FAULK: Open Payments
NPI 1528554508 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 37 payments from 9 companies in 2025. Trend: 2023 $1,678 · 2024 $822 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $565 |
| Janssen Biotech, Inc. | 4 | $79 |
| Enterra Medical, Inc. | 1 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Celltrion USA Inc. | 1 | $17 |
| Medline Industries LP | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: RINVOQ, SKYRIZI, TREMFYA, LINZESS, EOHILIA, ENTYVIO, TERLIVAZ, VEGZELMA.
Industry payments across TX — which companies pay providers there.
